Sepsis

Timely Diagnosis: Improving Outcomes in Sepsis and Antimicrobial Resistance

Improving outcomes with sepsis is dependent on timely diagnosis and treatment. Culture-independent testing is one way to save time.

Sepsis

T2 Biosystems CEO Shares Sepsis Survival Story in New Book

T2 Biosystems CEO John Sperzel has released a book about his personal experience with a bloodstream infection and sepsis, titled “Courage: Powerful Lessons in Leadership, Strength, and the Will to Succeed.”

Sepsis

Diagnostics Startups Take On Growing Threat of Antibiotic-Resistant Bugs

A new breed of diagnostic companies is rolling out technologies to tackle a growing and deadly health-care problem: antibiotic-resistant bugs

FDA Clears Early Sepsis Indicator from Beckman Coulter

Jun 9, 2019 | Culture Media, Sepsis

Beckman’s Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular biomarker for identifying patients with sepsis, or those at increased risk of developing sepsis.

Quality Control Media Help to Reduce Sepsis among Patients Requiring Platelet Transfusion

Jun 3, 2019 | Blood Banking, Culture Media, Hematology & Serology, Sepsis, Transfusion & Transplantation Tests

BD’s quality control media for platelet testing have been CE marked and cleared by FDA.

World Sepsis Day Raises Awareness of Deadly and Often Misdiagnosed Condition

Oct 20, 2018 | Microbiology, Research, Sepsis

The World Health Organization has declared sepsis a global health priority; 80% of sepsis deaths in hospitals could be prevented with rapid diagnosis and treatment.

Genetic Testing Prevents Antibiotic-Related Hearing Loss in Newborns Treated for Sepsis

Aug 6, 2018 | Research, Sepsis

A bedside test identifies infants with a genetic mutation of the mitochondrial DNA responsible for irreversible hearing loss as an adverse reaction to the antibiotic gentamicin.

Beckman Coulter Files FDA 510(k) Submission for Early Sepsis Indicator

Aug 6, 2018 | Hematology Instrumentation, Sepsis

Offered as part of a routine CBC with differential test, the hematology-based solution alerts emergency department clinicians to the possibility of sepsis earlier than any other indicator.

FDA Clears T2Bacteria Panel for the Detection of Sepsis-Causing Pathogens

Jun 26, 2018 | Infectious Diseases, Sepsis

The first FDA-cleared test to identify sepsis-causing bacteria from whole blood decreases time to diagnosis.

Beckman Coulter Sponsors Sepsis Clinical Guide App

May 18, 2018 | Information Technology, Sepsis, Standards

Beckman Coulter has exclusively sponsored the Escavo Sepsis Clinical Guide, a mobile, point-of-care medical reference application for healthcare professionals who manage septic patients in acute-care settings.

Baton Rouge General to Combat Sepsis with Wolters Kluwer Clinical Intelligence Platform

Dec 19, 2017 | Information Technology, Middleware & Software, Sepsis

The POC Advisor will be a central component of the hospital’s overall clinical and technology strategy.

Early Treatment of Sepsis Focus of Intensive Care Conference

Oct 30, 2017 | Research, Sepsis

Diagnosis and early treatment of sepsis was one of the focus areas for this year’s congress of the European Society of Intensive Care Medicine.

Integrated Decision Support Platform Tackles Sepsis

Aug 22, 2017 | Sepsis

Wolters Kluwer will integrate its POC Advisor real-time clinical surveillance and analytics platform with the Natural Language Processing solution from Hiteks Solutions for inclusion of structured and unstructured documentation to make them immediately actionable.

Category: Sepsis

Sepsis

Sepsis

Sepsis